ABSTRACT
The synthesized new binary conjugates of tetrahydro-γ-carbolines, which contained ditriazole spacers of different length, exhibited considerable anticholinesterase and antioxidant activity as well as the potential ability to block the acetylcholinesterase-induced aggregation of ß-amyloid in contrast to the original prototype Dimebon. This makes the compounds promising candidates for further investigation as drugs for the treatment of Alzheimer's disease. Special attention should be given to the conjugate containing the hexamethylene intertriazole spacer, which can be considered as a leader in this series of compounds.
Subject(s)
Antioxidants/chemistry , Carbolines/chemistry , Cholinesterase Inhibitors/chemistry , Alzheimer Disease/drug therapy , Animals , Antioxidants/therapeutic use , Carbolines/therapeutic use , Cholinesterase Inhibitors/therapeutic use , Indoles/chemistry , Indoles/therapeutic useABSTRACT
Using the acylation reaction with tosyl chloride of N-aminopropyl analogues of tacrine and its cyclic homologues with different size of the aliphatic cycle (5-8), we synthesized a number of new derivatives of p-toluenesulfonamide. It is shown that the synthesized hybrid compounds of tacrine and p-toluenesulfonamide are effective inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with the preferential inhibition of BChE. They also displace propidium from the peripheral anionic site of the electric eel AChE (Electrophorus electricus). The characteristics of the efficiency and selectivity of cholinesterase inhibition by the test compounds were confirmed by the results of molecular docking.
Subject(s)
Acetylcholinesterase/chemistry , Butyrylcholinesterase/chemistry , Cholinesterase Inhibitors , Electrophorus , Fish Proteins , Sulfonamides/chemistry , Tacrine/chemistry , Toluene/analogs & derivatives , Animals , Cholinesterase Inhibitors/chemical synthesis , Cholinesterase Inhibitors/chemistry , Fish Proteins/antagonists & inhibitors , Fish Proteins/chemistry , Toluene/chemistryABSTRACT
Conjugates of tacrine with 1,2,4-thiadiazole derivatives were synthesized for the first time. Their esterase profile and effects on the key NMDA receptor-binding sites as well as antioxidant activity were investigated. The obtained compounds effectively inhibited cholinesterases (with a predominant effect on butyrylcholinesterase), simultaneously blocked two NMDA receptor-binding sites (allosteric and intrachannel sites, and exhibited a high radical-scavenging activity. Our study shows that the obtained compounds are promising to design drugs for the treatment of Alzheimer's disease and other multifactorial neurodegenerative diseases.
Subject(s)
Antioxidants/pharmacology , Cholinesterase Inhibitors/chemistry , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Tacrine/chemistry , Thiadiazoles/chemistry , Butyrylcholinesterase/chemistry , Cholinesterase Inhibitors/pharmacology , Humans , Molecular Structure , Protein Binding/drug effects , Tacrine/pharmacology , Thiadiazoles/pharmacologyABSTRACT
A series of alkyl 2-Arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates was synthesized and their inhibitory activity with respect to porcine liver carboxylesterase (CaE, EC 3.1.1.1), human erythrocyte acetylcholinesterase (AChE, EC 3.1.1.7), and horse serum butyrylcholinesterase (BChE, EC 3.1.1.8) was studied. The molecular docking method was used to study the binding mode of the compounds in the active site of CaE. It was found that compounds containing the trifluoromethyl group in the third position of carbonyl chain are highly effective and selective inhibitors of CaE with nanomolar IC50 values, which agrees well with the results of molecular docking.
Subject(s)
Cholinesterase Inhibitors/chemistry , Cholinesterases/chemistry , Hydrazones/pharmacology , Molecular Docking Simulation , Propionates/pharmacology , Animals , Cholinesterase Inhibitors/pharmacology , Cholinesterases/metabolism , Horses , Humans , Hydrazones/chemistry , Propionates/chemistry , SwineABSTRACT
Acetylcholinesterase, butyrylcholinesterase, carboxylesterase, and paraoxonase activities in human, mouse, and rat blood were measured. The proportions of these enzymes activities differed significantly. In humans, the most significant were cholinesterase activities, while in rats and mice the contribution of carboxylesterase activity was the greatest. High arylesterase activity of paraoxonase was observed in all cases. Species-specific differences should be taken into consideration when carrying out preclinical trials on rodents for optimization of the pharmacokinetic characteristics of drugs containing complex ester groups.
